Search Results 91-100 of 15146 for infliximab

  1. Rituximab and hyaluronidase human, recombinant (subcutaneous route) - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Lidocaine; Measles Virus Vaccine, Live; Mepivacaine Hydrochloride; Mumps Virus Vaccine, Live; Poliovirus Vaccine, ...

  2. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy - Mayo Clinic

    ... infliximab, adalimumab, or certolizumab pegol). Exclusion Criteria: Subjects with ulcerative colitis (UC), collagenous colitis or indeterminate colitis ...

  3. Natalizumab-sztn (intravenous route) - Mayo Clinic

    Infliximab; Vedolizumab. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating certain types of food since ...

  4. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    At least one 6-week induction regimen of infliximab (≥5 mg/kg IV at Weeks 0 ... Approved biologics: infliximab, adalimumab, certolizumab, vedolizumab ...

  5. Brodalumab (subcutaneous route) - Mayo Clinic

    Haloperidol; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus Vaccine, Live; Poliovirus Vaccine, Live; Roflumilast; Rotavirus ...

  6. Adalimumab-atto (subcutaneous route) - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Levoketoconazole; Measles Virus Vaccine, Live; Mercaptopurine; Methotrexate; Mumps Virus Vaccine, Live; Poliovirus ...

  7. Publications - Maria Alice V. Willrich, Ph.D. - Mayo Clinic

    ... Infliximab and Adalimumab Without Acid Dissociation. ... Comparison of Clinical Laboratory Assays for Measuring Serum Infliximab and Antibodies to Infliximab.

  8. A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    At least one 6-week induction regimen of infliximab (≥ 5 mg/kg intravenous [IV] ... approved biologic agent (e.g., infliximab, adalimumab, golimumab ...

  9. Could Pain in the Finger Joints Be a Sign of Rheumatoid Arthritis? - Mayo Clinic News Network

    Medications in this category include infliximab (Remicade) and etanercept (Enbrel). Work closely with a rheumatologist to determine the treatment approach ...

  10. Psoriasis - Diagnosis and treatment - Mayo Clinic

    It's less effective than adalimumab and infliximab. It might cause upset stomach, loss of appetite and fatigue. People taking methotrexate long-term need ...